Roche Opens Boston Innovation Center for CVRM Research
BASEL, Switzerland — September 17, 2026 Roche announced the grand opening of the Roche Genentech Innovation Center Boston, expanding...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BASEL, Switzerland — September 17, 2026 Roche announced the grand opening of the Roche Genentech Innovation Center Boston, expanding...
INGELHEIM, Germany — September 17, 2026 Boehringer Ingelheim announced the launch of PED Essentials, a free online learning hub...
BAGSVAERD, Denmark — September 14, 2026 Novo Nordisk A/S announced the launch of a new corporate brand centred on...
Columbus, Ohio, September 1, 2026 Andelyn Biosciences has announced that Genprex, Inc. has selected the contract development and manufacturing...
Dublin, Ireland, September 1, 2026 Keenova Therapeutics plc has announced new initiatives for the second annual National Hand Health...
Stockholm, Sweden, August 19, 2026 BioArctic AB and Mesenkia Therapeutics have entered a research collaboration to explore a novel...
Ramat Gan, Israel, August 19, 2026 Pulsenmore Ltd. announced the expansion of its home ultrasound activities in Israel following...
BURLINGTON, N.C. and BETHESDA, Md., August 18, 2026 Labcorp and the National Association of Community Health Centers (NACHC) announced...
PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...
AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutiva™...
